CD4 and HIV infectious disease: In a carefully selected population of patients on HAART with CD4+ T-cell counts of at least 200 per cubic millimeter and undetectable plasma HIV type 1 (HIV-1) RNA levels, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection.